SCLY and cancer: Cancer cells may increase the uptake of Se through system Xc− or as SELENOP through LRP8 receptor to protect the cell from ferroptotic cell death, while also modulating key enzymes of the trans-selenation pathway, such as CBS, CGL, or SCLY.